Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?

Fig. 1

Therapeutic approach of the 47-Brazilian patients with PCNSL included in the study. PCNSL primary central nervous system lymphoma, HD-MTX high-dose methotrexate, CCT combined consolidation therapy, HD-cytarabine high-dose cytarabine, MRI magnetic resonance imaging, CSF cerebrospinal fluid, CR complete response, PR partial response, WBRT whole-brain radiotherapy, IT intratecal, R/R relapsed/refractory disease, DeVIC dexamethasone, etoposide, ifosfamide and carboplatin, M-IVAC methotrexate, ifosfamide, etoposide, cytarabine. ***Among the 13 patients with late-relapse, only 5 cases received HD-MTX-based rescue therapy. The remaining 8 patients died before a new treatment

Back to article page